- Home
- SHMD vs RAPT Comparison
SHMD vs RAPT Comparison
Compare SHMD & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHMD
- RAPT
- Stock Information
- Founded
- SHMD 1864
- RAPT 2015
- Country
- SHMD Germany
- RAPT United States
- Employees
- SHMD N/A
- RAPT N/A
- Industry
- SHMD
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- SHMD
- RAPT Health Care
- Exchange
- SHMD Nasdaq
- RAPT Nasdaq
- Market Cap
- SHMD 112.0M
- RAPT 122.9M
- IPO Year
- SHMD N/A
- RAPT 2019
- Fundamental
- Price
- SHMD $2.56
- RAPT $11.74
- Analyst Decision
- SHMD
- RAPT Buy
- Analyst Count
- SHMD 0
- RAPT 5
- Target Price
- SHMD N/A
- RAPT $33.60
- AVG Volume (30 Days)
- SHMD 14.6K
- RAPT 105.9K
- Earning Date
- SHMD 02-25-2025
- RAPT 08-07-2025
- Dividend Yield
- SHMD N/A
- RAPT N/A
- EPS Growth
- SHMD N/A
- RAPT N/A
- EPS
- SHMD N/A
- RAPT N/A
- Revenue
- SHMD $85,165,542.00
- RAPT N/A
- Revenue This Year
- SHMD N/A
- RAPT N/A
- Revenue Next Year
- SHMD N/A
- RAPT N/A
- P/E Ratio
- SHMD N/A
- RAPT N/A
- Revenue Growth
- SHMD N/A
- RAPT N/A
- 52 Week Low
- SHMD $1.86
- RAPT $5.67
- 52 Week High
- SHMD $4.40
- RAPT $26.56
- Technical
- Relative Strength Index (RSI)
- SHMD N/A
- RAPT 58.44
- Support Level
- SHMD N/A
- RAPT $10.20
- Resistance Level
- SHMD N/A
- RAPT $13.50
- Average True Range (ATR)
- SHMD 0.00
- RAPT 1.01
- MACD
- SHMD 0.00
- RAPT -0.05
- Stochastic Oscillator
- SHMD 0.00
- RAPT 77.46
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.